PUBLIC HEALTH ALERT:SALE OF COVID-19 VACCINES

FDA Ghana (wpDataTable) — alert from the official newsroom listing (source index). Official notice file: PDF. — Official PDF notice (extracted text) — oRUGS 0 "" IL < \bur Wt/1-btlng, Our Priority. FDA/CPE/PR/21/0001 FOR IMMEDIATE RELEASE PRESS RELEASE Head Office Mail: P.O. Box CT 2783, Cantonments-Accra, Ghana ( +233)-302-233200/235100 (+233)-299-802932/3 (Hotline) Email: fda@fdaghana.gov.gh Digital Address: GA-237-7316 12 1h January 2021 PUBLIC HEAL TH ALERT: SALE OF COVID-19 VACCINES It has come to the attention of the Food and Drugs Authority (FDA), that some unscrupulous members of the business community are peddling information on the sale of COVI D-19 vaccines to hospitals and other health facilities. The information is ostensibly to inform the general public of the availability of these vaccines from well- known pharmaceutical brands indicating their price ranges. The general public is hereby cautioned against the patronage of such vaccines since the FDA has not yet approved any COVID-19 vaccine for use in Ghana. In view of the above, the FDA wishes to inform all health facilities and the general public that, peddling of such information contravenes Section 118 of the Public Health Act 2012, Act 851 and constitutes a very serious offence. The Authority wants to assure the general public that it remains committed to protecting the health and safety of consumers. To this end, it monitors social media and online activities pertaining to the products it regulates; therefore, anyone caught dealing with unregistered COVID-19 vaccine will be sanctioned in accordance with the provisions of Section 129 of Act 851, which includes a fine of up to GHC 180,000 or to a term of imprisonment of up to 25 years or both. Please note that when the COVID-19 vaccine is approved by the FDA for use in Ghana, the Ministry of Health will issue a national policy on the use of COVID-19 vaccines throughout the health sector. All concerns and questions arising out of this publication as well as any other FDA regulated products can be directed to the Authority on the following contacts: m 0299802932 or 0299802933 4015 (On Vodafone, MTN and AirtelTigo) SJ fdaghana fdaghana_ Signed DELESE A. A. DARKO (MRS.) CHIEF EXECUTIVE OFFICER f) 0206973065 @) www.fdaghana.gov.gh O fdaghana ISO 900 l (2015) Certified Institution, ISO 17025(2017) Accredited Laboratory, Regional Centre for Regulatory Excellence (RCORE) in Clinical Trials, Pharmacovigilance and Drug Registration